Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?

Muhammad Abdul-Ghani

Producción científica: Comment/debate › revisión exhaustiva

43 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?'. En conjunto forman una huella única.